Today the FIRST ® in
Texas Foundation , a nonprofit dedicated to funding, training and
supporting FIRST ® Robotics programs across
the state of Texas, announced it will be the sole beneficiary of funds
raised by the Freescale
Foundation during the 2015 Austin
Marathon and Half Marathon , presented by Freescale.
Veterans on Wall Street (VOWS), a consortium of major financial
institutions including Citi, Deutsche Bank and Goldman Sachs, held their
fourth annual Veteran Employment Symposium and Resource Fair on November
5 th in New York City.
As a founding member of Thread Group, an industry alliance focused on
creating a simple, secure and low-power network for the connected home,
Freescale Semiconductor (NYSE: FSL) announced today its Thread beta
By Sara Sjolin, MarketWatch
LONDON (MarketWatch) -- The U.K.'s FTSE 100 index climbed for a fifth straight day on Tuesday, led by Vodafone Group PLC that advanced after a well-received earnings report.
Trial expands the eligible patient population and overall NeuVax clinical trial portfolio Recent patent allowance provides intellectual property protection for NeuVax in combination with Herceptin in any HER2/neu expressing cancer
PORTLAND, Ore., Nov.
Sign-up for Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Combination With Herceptin(R) (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breast Cancer Patients investment picks
GE Healthcare and Takeda Pharmaceutical Company announced that they have
entered into an alliance agreement for research and development in the
field of hepatic fibrosis, a key factor in the diagnosis and treatment
of liver diseases.
Before the holiday shopping season kicks into high gear, Sprint (NYSE:
S) will offer Nexus 6 with 2.5GHz LTE data speeds and a pure Android™
experience coupled with rate plans like the Sprint
Family Share Pack offering the best value for families who want
Reports EPS of ($0.01)
Ended the third quarter with cash and cash equivalents of $14.0 million
Isobutanol production rates accelerate following the commissioning of the final phase of capital equipment for Side-by-Side operational mode
Total supplying Formula 1 ® racing fuel containing Gevo's renewable isooctane
Gulf Racing Fuels selling high performance fuels using Gevo's renewable isobutanol
ENGLEWOOD, Colo., Nov.
Gilead Sciences, Inc. (Nasdaq:GILD) today announced data from three
Phase 2 open-label studies evaluating the safety and efficacy of an
investigational all-oral pan-genotypic regimen containing the nucleotide
analog polymerase inhibitor sofosbuvir (SOF), approved as Sovaldi ®
by the U.S. Food and Drug Administration in December 2013, and the
investigational NS5A inhibitor GS-5816 for the treatment of chronic
hepatitis C virus (HCV) infection.
GNCC Capital, Inc. (OTC:GNCP) (“The Company”) announced on September 29,
2014 and confirmed on October 30, 2014, that its Board of Directors
intended to recommend re-domiciling the Company from Delaware to
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.